GSAM 2025 Annual Conference

No products in the cart.

GSAM 2025 Annual Conference

No products in the cart.

Legislation

Home Archive "Legislation"
DEA Rules Extend Controlled Substance Telemedicine
Addiction Medicine Updates Articles of Interest Legislation

New DEA Rule Extends Controlled Substance Telemedicine Prescribing Flexibilities One More Year

The Drug Enforcement Administration (DEA) just released a new regulation temporarily extending the COVID-era flexibilities for prescribing controlled substances via telemedicine. This third extension continues the “full set” of telemedicine prescribing flexibilities, referencing the two DEA letters that authorized telemedicine waivers, with a new expiration date of December 31, 2025....
U.S. Supreme Court Refuses to Hear Tobacco Industry’s Challenge to Graphic Cigarette Warnings
Articles of Interest Legislation

In Victory for Public Health, U.S. Supreme Court Refuses to Hear Tobacco Industry’s Challenge to Graphic Cigarette Warnings

Today’s Supreme Court decision is a giant step toward finally implementing graphic cigarette warnings in the United States. Graphic warnings are a best-practice policy, and they are long-overdue in the United States. These warnings were first required by Congress in 2009 and have been repeatedly delayed by tobacco industry legal challenges. The graphic warnings will show and tell the...
DEA and HHS Extend Telemedicine Flexibilities through 2025
Addiction Medicine Updates Legislation

DEA and HHS Extend Telemedicine Flexibilities through 2025

In 2023, in response to a set of proposed telemedicine rules, DEA received more than 38,000 comments and held two days of public listening sessions. In light of that feedback and discussion, and to give DEA time to consider a new path forward for telemedicine, DEA and the Department of Health and Human Services (HHS) extended current telemedicine flexibilities through the end of 2024....
Pending DEA Extension on Prescription of Controlled Substances via Telemedicine
Addiction Medicine Updates Articles of Interest Legislation

Pending DEA Extension on Prescription of Controlled Substances via Telemedicine

A new rule posted on the Office of Management and Budget (OMB) registry suggests that the Drug Enforcement Administration (DEA) is planning an additional extension of COVID-19 flexibilities for telemedicine prescribing of controlled substances, beyond the current expiration date of December 31, 2024. A new rule posted on the Office of Management and Budget (OMB) registry suggests that...
CENTERS FOR MEDICARE MEDICAID (CMS) PUBLISHES FINAL RULES OUTLINING PAYMENT POLICIES FOR CALENDAR YEAR 2025
Articles of Interest Legislation

Medicare Finalizes New Payment Policies for 2025

On November 1, 2024, the Centers for Medicare and Medicaid Services (CMS) published final rules outlining payment policies for the calendar year (CY) 2025 payment year. The 2025 finalized MPFS proposes certain policy changes and some newly covered services that will enhance the care continuum. ASAM has provided a summary of these finalized changes below as well as at this link where...
STAKEHOLDERS URGE CONGRESS TO PASS THE MODERNIZING OPOIOD TREATMENT ACCESS ACT
Legislation

Update on Modernization of Opiod Treatment Access Act (S.644/H.R. 1359)

More than 125 organizations submitted a joint letter to Congressional leaders today urging them to address the demand-side of America’s overdose crisis by prioritizing the bipartisan legislation in any year-end legislative package Washington, DC (Nov. 12, 2024) – Today, more than 125 organizations representing a broad base of stakeholders submitted a joint letter to House and Senate...
Overdose Deaths are declining: But Not in Black Communities
Articles of Interest Education Legislation

Overdose deaths are declining. But Not in Black Communities

For years, we’ve read saddening stories in newspapers like this one about the horrific effects of the overdose crisis on Hoosiers. Stories about lives lost, families torn apart and communities grieving. But in mid-May, we read a story that wasn’t sad. A story that gave us hope. The Centers for Disease Control and Prevention revealed preliminary 2023 data showing overdose deaths...
Bill removes mandated report to law enforcement of positive drug tests in newborns
Addiction Medicine Updates Legislation

Bill Removes Mandated Report to Law Enforcement of Positive Drug Tests in Newborn

Bill removes mandated report to law enforcement of positive drug tests in newborns By Catrina Petersen | The Center Square (The Center Square) – The legislature is ready to send a bill to Illinois Gov. J.B. Pritzker that removes the mandate that the Department of Children and Family Services must report newborn babies’ positive toxicology screens to law enforcement. Senate Bill 3136...
Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder
Articles of Interest Legislation

Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder

Summary: The Federation of State Medical Boards (FSMB) has released a Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder, emphasizing the ongoing opioid overdose crisis in the United States, which saw over 107,000 deaths in 2022 despite declining prescription rates for opioid analgesics. The statement highlights the low treatment rates with Medications...
Doctors-and-Pharmacists-Groups-Send-Joint-Letter-to-DEA,-HHA,-ONDCP,-and-SAMHSA-on-Buprenorphine-Access-Issues
Addiction Medicine Updates Legislation

Doctors and Pharmacists Groups Send Joint Letter to DEA, HHA, ONDCP, and SAMHSA on Buprenorphine Access Issues:

Today, the American Society of Addiction Medicine (ASAM) joined the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) in a joint letter to the Drug Enforcement Administration (DEA), Substance Abuse and the Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services...